Detalles de la búsqueda
1.
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion.
Biol Blood Marrow Transplant
; 24(3): 507-513, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29196078
2.
Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT.
Biol Blood Marrow Transplant
; 23(1): 44-52, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27720995
3.
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.
Haematologica
; 102(1): 160-167, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27634201
4.
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation.
Leuk Lymphoma
; 60(10): 2404-2414, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30997844
5.
Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT.
Clin Lymphoma Myeloma Leuk
; 17(10): 667-675.e2, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28694085
Resultados
1 -
5
de 5
1
Próxima >
>>